Esophageal Achalasia: PPI Treatment Study

We are exploring whether routine use of a medication for acid reflux is better than using it only when needed after a procedure for esophageal achalasia. This study aims to improve treatment outcomes and quality of life for patients.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Lansoprazole
Lansoprazole is a medicine that reduces stomach acid to treat heartburn, acid reflux, and stomach ulcers.
Lansoprazole Sandoz
Lansoprazole Sandoz is a medicine that reduces stomach acid to treat heartburn, ulcers, and other acid-related stomach problems.

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Lansoprazole
Lansoprazole is a substance that reduces stomach acid to treat heartburn, acid reflux, and stomach ulcers.

What similar medicines might you know?

Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.

Agopton
Agopton
Alexin

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Assistance Publique Hopitaux De Marseille
hepato-gastro-enterology
Marseille, France
Centre Hospitalier Universitaire De Nimes
hepato-gastro-enterology
Milhaud, France
Centre Hospitalier Universitaire De Montpellier
Gastroenterology
Montpellier, France

Sponsor: CHU de Nimes
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.